Walgreen's March Sales Fall as Fewer Get Sick

By RetailFOXBusiness

Walgreen (NYSE:WAG) reported on Wednesday a 4.3% drop in March sales, as stronger front-end revenue could not wholly offset a wide decline in the number of prescriptions filled by patients.

A lower incidence of flu and colds during the warmer-than-usual winter, as well as the loss of a prescription contract with Express Scripts, led to an 11.4% decline in prescriptions during March.

Continue Reading Below

That hurt pharmacy sales by 8.4%.

Front-end sales grew 2.5% leading up to the Easter season, as higher basket sizes offset a slight decline in customer traffic. The company also attributed the growth to its new weekly ad circular launched in mid-February that provides online savings.

The weak start to Walgreen’s third quarter follows a narrowed second-quarter profit amid soft pharmacy sales. The company last month blamed the results on what it called the mildest flu season in 29 years.

What do you think?

Click the button below to comment on this article.